Following on from the ISREC Symposia in 2011 to 2016, the next ISREC Symposium, to be held in Lausanne in September 2018, will focus on broad themes – horizons – in cancer biology and therapy. This symposium will also present the new multi–institutional Swiss Cancer Center (SCC) which leverages complementary expertise from our partner institutions: the University Hospital & Medical Center (CHUV) of the University of Lausanne (UNIL) , the Swiss Federal Institute of Technology Lausanne (EPFL), Ludwig Cancer Research (Ludwig), the University Hospital & Medical Center (HUG) of the University of Geneva (UNIGE), the Swiss Institute for Bioinformatics (SIB) and the ISREC Foundation. An exciting roster of basic, translational, and clinical cancer scientists will present their latest results and implications:
The 2018 ISREC-SCC Symposium will present an excellent opportunity to hear the latest results from and interact with exceptional cancer researchers, in the context of invited talks, short talks selected from proffered abstracts, and posters. Topics to be covered include all of the hallmarks of cancer, with a focus on tumor immunology and mechanism-guided therapies. We envision an inspirational gathering.
- Cancer Genetics
- Cancer Metabolism
- Tumor Microenvironment
- Therapeutic Strategies & Drug Design
- Metastasis and Cancer Stem Cells
CONFERENCE REGISTRATION will open in early 2018. Stay tuned for further messages.
The Organizing Committee
Doug Hanahan, Johanna Joyce, Ping-Chih Ho, Elisa Oricchio, Michele de Palma, George Coukos, Gian-Paolo Dotto, Joerg Huelsken